ES2943252T3 - Fumarato de (+)-3-(2,3-difluorofenil)-3-metoxipirrolidina, un proceso para su preparación y sus usos - Google Patents
Fumarato de (+)-3-(2,3-difluorofenil)-3-metoxipirrolidina, un proceso para su preparación y sus usos Download PDFInfo
- Publication number
- ES2943252T3 ES2943252T3 ES18730980T ES18730980T ES2943252T3 ES 2943252 T3 ES2943252 T3 ES 2943252T3 ES 18730980 T ES18730980 T ES 18730980T ES 18730980 T ES18730980 T ES 18730980T ES 2943252 T3 ES2943252 T3 ES 2943252T3
- Authority
- ES
- Spain
- Prior art keywords
- salt
- formula
- compound
- disorder
- formula iib
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/11—Compounds covalently bound to a solid support
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17171938 | 2017-05-19 | ||
| EP17195451 | 2017-10-09 | ||
| EP17207406 | 2017-12-14 | ||
| EP18151428 | 2018-01-12 | ||
| PCT/EP2018/063123 WO2018211080A1 (en) | 2017-05-19 | 2018-05-18 | (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine or pharmaceutically acceptable salts thereof, a process for preparation thereof and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2943252T3 true ES2943252T3 (es) | 2023-06-12 |
Family
ID=62599537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18730980T Active ES2943252T3 (es) | 2017-05-19 | 2018-05-18 | Fumarato de (+)-3-(2,3-difluorofenil)-3-metoxipirrolidina, un proceso para su preparación y sus usos |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US11078158B2 (OSRAM) |
| EP (1) | EP3625213B1 (OSRAM) |
| JP (1) | JP7126522B2 (OSRAM) |
| CN (1) | CN110621659B (OSRAM) |
| CA (1) | CA3064136A1 (OSRAM) |
| DK (1) | DK3625213T3 (OSRAM) |
| ES (1) | ES2943252T3 (OSRAM) |
| FI (1) | FI3625213T3 (OSRAM) |
| PL (1) | PL3625213T3 (OSRAM) |
| WO (1) | WO2018211080A1 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3976581B1 (en) * | 2019-05-24 | 2023-11-22 | Irl 790 AB | Tartaric acid salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine |
| BR112022025065A2 (pt) * | 2020-06-10 | 2022-12-27 | Epics Therapeutics | Síntese de ácido (2s,5r)-5-(2-clorofenil)-1-(2'-metoxi-[1,1'-bifenil]-4- carbonil)pirrolidina-2-carboxílico |
| WO2025003437A1 (en) | 2023-06-28 | 2025-01-02 | Integrative Research Laboratories Sweden Ab | A pharmaceutical composition comprising a fumaric acid salt of (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0586229A1 (en) | 1992-09-01 | 1994-03-09 | Zeneca Limited | 3-Hydroxy-3-(subst-akyl)-pyrrolidines as 5-lipoxygenase inhibitors |
| EP1582524B1 (en) | 2004-04-02 | 2008-08-13 | Ludwig Maximilians Universität | Method of preparing organomagnesium compounds |
| KR20100038295A (ko) * | 2007-06-05 | 2010-04-14 | 엔에스아베 필리알 아프 뉴로서치 스웨덴 아베 스베리게 | 피질 카테콜아민성 신경 전달의 조정자로서의 이치환된 페닐피롤리딘 |
| KR101660936B1 (ko) * | 2008-11-24 | 2016-10-05 | 인터그레이티브 리서치 래버러토리즈 스웨덴 에이비 | 피질 카테콜아민성 신경전달의 조절자로서의 3-페닐-3-메톡시피롤리딘 유도체 |
| CN106957252B (zh) * | 2014-11-19 | 2019-11-19 | 连云港恒运药业有限公司 | 一种质子泵抑制剂中间体及其制备方法 |
-
2018
- 2018-05-18 US US16/338,055 patent/US11078158B2/en active Active
- 2018-05-18 WO PCT/EP2018/063123 patent/WO2018211080A1/en not_active Ceased
- 2018-05-18 JP JP2019563863A patent/JP7126522B2/ja active Active
- 2018-05-18 PL PL18730980.2T patent/PL3625213T3/pl unknown
- 2018-05-18 ES ES18730980T patent/ES2943252T3/es active Active
- 2018-05-18 FI FIEP18730980.2T patent/FI3625213T3/fi active
- 2018-05-18 EP EP18730980.2A patent/EP3625213B1/en active Active
- 2018-05-18 CN CN201880031878.8A patent/CN110621659B/zh active Active
- 2018-05-18 CA CA3064136A patent/CA3064136A1/en active Pending
- 2018-05-18 DK DK18730980.2T patent/DK3625213T3/da active
-
2021
- 2021-06-25 US US17/358,494 patent/US12091384B2/en active Active
-
2024
- 2024-08-13 US US18/802,081 patent/US20240400505A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20200024231A1 (en) | 2020-01-23 |
| EP3625213A1 (en) | 2020-03-25 |
| WO2018211080A1 (en) | 2018-11-22 |
| JP7126522B2 (ja) | 2022-08-26 |
| DK3625213T3 (da) | 2023-04-24 |
| US20240400505A1 (en) | 2024-12-05 |
| JP2020520936A (ja) | 2020-07-16 |
| CA3064136A1 (en) | 2018-11-22 |
| FI3625213T3 (fi) | 2023-05-29 |
| US20210317081A1 (en) | 2021-10-14 |
| US12091384B2 (en) | 2024-09-17 |
| CN110621659A (zh) | 2019-12-27 |
| EP3625213B1 (en) | 2023-03-08 |
| US11078158B2 (en) | 2021-08-03 |
| CN110621659B (zh) | 2023-02-28 |
| PL3625213T3 (pl) | 2023-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240400505A1 (en) | (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine or pharmaceutically acceptable salts thereof, a process for preparation thereof and uses thereof | |
| KR102892833B1 (ko) | [2-(3-플루오로-5-메탄-술포닐페녹시)에틸](프로필)아민의 제약상 허용되는 염 및 그의 용도 | |
| ES2648512T3 (es) | Derivados de carbamato/urea | |
| US20230312573A1 (en) | Novel salts, crystals, and co-crystals | |
| KR102768447B1 (ko) | (-)-시벤졸린 숙신산염의 신규한 제조 공정 | |
| KR20240054327A (ko) | Bcl-2 저해제의 고체 형태, 제조 방법 및 이의 용도 | |
| HK40012481A (en) | (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine or pharmaceutically acceptable salts thereof, a process for preparation thereof and uses thereof | |
| WO2025008504A1 (en) | Pharmaceutically acceptable salts of 3-(2,3-difluorophenoxy)azetidine and uses thereof | |
| HK40012481B (en) | (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine or pharmaceutically acceptable salts thereof, a process for preparation thereof and uses thereof | |
| EA047399B1 (ru) | Фармацевтически приемлемые соли [2-(3-фтор-5-метансульфонилфенокси)этил](пропил)амина и их применение | |
| HK40063249A (en) | Pharmaceutically acceptable salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine and uses thereof | |
| HK1204609B (en) | Carbamate/urea derivatives |